A Avogaro, G Toffolo, E Kiwanuka, SV de … - Diabetes, 2003 - Am Diabetes Assoc Defective endothelium is a key event in the development of atherosclerosis in
diabetes: alteration of the l-arginine-nitric oxide (NO) pathway has been
suggested. We propose a modeling approach of the l-arginine-NO pathway in ... Related articles - All 2 versions
A Stable-Labelled, NA Approach - DIABETES, 2003 - Am Diabetes Assoc L -Arginine–Nitric Oxide Kinetics in Normal and Type 2 ... A Stable-Labelled
15 N Arginine Approach ... Angelo Avogaro, 1 Gianna Toffolo, 2 Edward Kiwanuka,
1 Saula Vigili de Kreutzenberg, 1 Paolo Tessari, 1 Related articles
P Forte, LM Smith, E Milne, N Benjamin - Methods in enzymology, 1999 - ncbi.nlm.nih.gov 1: Methods Enzymol. 1999;301:92-8. Measurement of nitric oxide synthesis in humans
using L-[15N2]arginine. Forte P, Smith LM, Milne E, Benjamin N. ... Cited by 7 - Related articles - BL Direct - All 2 versions
HM Farouque, IT Meredith - Coronary Artery Disease, 2001 - journals.lww.com Endothelial dysfunction can be broadly defined as impairment in any of the
normal functions of the endothelium caused by an injurious stimulus. This change
is widely regarded as an early event in the process of atherogenesis [ 2 ], ... Cited by 18 - Related articles - BL Direct - All 4 versions
PD O'Kane, G Jackson, A Ferro - Atherosclerosis, 2008 - Elsevier Vascular endothelial nitric oxide (NO) biosynthesis is reported to be decreased
in patients with atherosclerosis. The primary aim of the present study was to
determine whether whole body NO production is decreased in patients with ... Cited by 2 - Related articles - All 42 versions
S Mochizuki, E Toyota, O Hiramatsu, T Kajita … - Heart and Vessels, 2000 - Springer Abstract It is of great interest and value to evaluate the systemic nitric oxide
(NO) production rate in humans under various conditions. However, the currently
available esti- mation methods are troublesome and time-consuming. We thus ... Cited by 11 - Related articles - BL Direct - All 6 versions
- ►physiology.org P Tessari, A Coracina, L Puricelli, M Vettore … - American Journal of Physiology- Endocrinology And …, 2007 - Am Physiological Soc Nitric oxide (NO) is a key regulatory molecule with wide vascular, cellular, and
metabolic effects. Insulin affects NO synthesis in vitro. No data exist on the
acute effect of insulin on NO kinetics in vivo. By employing a ... Cited by 2 - Related articles - BL Direct - All 4 versions
YC Luiking, NEP Deutz - Current Opinion in Clinical Nutrition & Metabolic Care, 2003 - journals.lww.com Purpose of review: Nitric oxide is an important mediator of both physiological
and pathophysiological processes. Nitric oxide is produced during direct
conversion of arginine to citrulline. Nitric oxide is rapidly metabolized, ... Cited by 25 - Related articles - BL Direct - All 3 versions
- ►nih.gov T Lau, W Owen, YM Yu, N Noviski, J Lyons, D … - Journal of Clinical Investigation, 2000 - Am Soc Clin Investig The kidneys are thought to be a major site of net de novo arginine synthesis,
but the quantitative status of arginine metabolism and its substrate precursor
relationship to nitric oxide (NO) synthesis in end stage renal disease ... Cited by 56 - Related articles - BL Direct - All 6 versions
- ►critcaremed.com P Forte, MR OGBORN, T LILLEY-CHAN - Pediatric research, 2006 - journals.lww.com Department of Pharmacology and Therapeutics [PF], University of Manitoba, R3E
OT6 Winnipeg, Manitoba, Canada; The Manitoba Institute of Child Health [PF, MRO,
TL-C.], R3E 3P4 Winnipeg, Manitoba, Canada ... ABSTRACT: Determination of ... Cited by 1 - Related articles - BL Direct - All 5 versions
